Funding good until well past Phase IIa results, proven results on using substituted 8-quinolinols for treatment of AD, exceptional metal chelation agents, PBT2 improvement on PBT1, then onto the possibility of treating Parkinsons and others.
Looking to top up, good luck.
- Forums
- ASX - By Stock
- looking good
ATH
alterity therapeutics limited
Add to My Watchlist
0.00%
!
0.9¢

Funding good until well past Phase IIa results, proven results...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.14M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $30.3K | 3.366M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 15846771 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 16640020 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
41 | 15846771 | 0.009 |
24 | 12587436 | 0.008 |
20 | 11987963 | 0.007 |
15 | 8363518 | 0.006 |
9 | 5485001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 16636995 | 12 |
0.011 | 12159705 | 29 |
0.012 | 15337857 | 27 |
0.013 | 7625068 | 13 |
0.014 | 12798180 | 7 |
Last trade - 11.03am 03/07/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online